Suppr超能文献

伽玛刀放射外科治疗后无功能垂体腺瘤的肿瘤再生长特征及重复伽玛刀放射外科治疗的结果

Characteristic of Tumor Regrowth After Gamma Knife Radiosurgery and Outcomes of Repeat Gamma Knife Radiosurgery in Nonfunctioning Pituitary Adenomas.

作者信息

Li Yanli, Wu Lisha, Quan Tingting, Fu Junyi, Cao Linhui, Li Xi, Liang Shunyao, Huang Minyi, Deng Yinhui, Yu Jinxiu

机构信息

Department of Endocrinology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Front Oncol. 2021 Mar 5;11:627428. doi: 10.3389/fonc.2021.627428. eCollection 2021.

Abstract

OBJECTIVE

This study aimed to report the characteristic of tumor regrowth after gamma knife radiosurgery (GKRS) and outcomes of repeat GKRS in nonfunctioning pituitary adenomas (NFPAs).

DESIGN AND METHODS

This retrospective study consisted of 369 NFPA patients treated with GKRS. The median age was 45.2 (range, 7.2-84.0) years. The median tumor volume was 3.5 (range, 0.1-44.3) cm.

RESULTS

Twenty-four patients (6.5%) were confirmed as regrowth after GKRS. The regrowth-free survivals were 100%, 98%, 97%, 86% and 77% at 1, 3, 5, 10 and 15 year, respectively. In multivariate analysis, parasellar invasion and margin dose (<12 Gy) were associated with tumor regrowth (hazard ratio [HR] = 3.125, 95% confidence interval [CI] = 1.318-7.410, p = 0.010 and HR = 3.359, 95% CI = 1.347-8.379, p = 0.009, respectively). The median time of regrowth was 86.1 (range, 23.2-236.0) months. Previous surgery was associated with tumor regrowth out of field (p = 0.033). Twelve patients underwent repeat GKRS, including regrowth in (n = 8) and out of field (n = 4). Tumor shrunk in seven patients (58.3%), remained stable in one (8.3%) and regrowth in four (33.3%) with a median repeat GKRS margin dose of 12 (range, 10.0-14.0) Gy. The actuarial tumor control rates were 100%, 90%, 90%, 68%, and 68% at 1, 3, 5, 10, and 15 years after repeat GKRS, respectively.

CONCLUSIONS

Parasellar invasion and tumor margin dose (<12 Gy) were independent risk factors for tumor regrowth after GKRS. Repeat GKRS might be effective on tumor control for selected patients. For regrowth in field due to relatively insufficient radiation dose, repeat GKRS might offer satisfactory tumor control. For regrowth out of field, preventing regrowth out of field was the key management. Sufficient target coverage and close follow-up might be helpful.

摘要

目的

本研究旨在报告伽玛刀放射外科治疗(GKRS)后无功能垂体腺瘤(NFPA)的肿瘤再生长特征及重复GKRS的疗效。

设计与方法

这项回顾性研究纳入了369例接受GKRS治疗的NFPA患者。中位年龄为45.2岁(范围7.2 - 84.0岁)。中位肿瘤体积为3.5 cm(范围0.1 - 44.3 cm)。

结果

24例患者(6.5%)在GKRS后被证实肿瘤再生长。1年、3年、5年、10年和15年的无再生长生存率分别为100%、98%、97%、86%和77%。多因素分析显示,鞍旁侵犯和边缘剂量(<12 Gy)与肿瘤再生长相关(风险比[HR]=3.125,95%置信区间[CI]=1.318 - 7.410,p = 0.010;HR = 3.359,95% CI = 1.347 - 8.379,p = 0.009)。再生长的中位时间为86.1个月(范围23.2 - 236.0个月)。既往手术与野外肿瘤再生长相关(p = 0.033)。12例患者接受了重复GKRS,包括野内再生长(n = 8)和野外再生长(n = 4)。7例患者(58.3%)肿瘤缩小,1例(8.3%)稳定,4例(33.3%)再生长,重复GKRS的中位边缘剂量为12 Gy(范围10.0 - 14.0 Gy)。重复GKRS后1年、3年、5年、10年和15年的精算肿瘤控制率分别为100%、90%、90%、68%和68%。

结论

鞍旁侵犯和肿瘤边缘剂量(<12 Gy)是GKRS后肿瘤再生长的独立危险因素。重复GKRS对部分患者的肿瘤控制可能有效。对于因放射剂量相对不足导致的野内再生长,重复GKRS可能提供满意的肿瘤控制。对于野外再生长,防止野外再生长是关键管理措施。足够的靶区覆盖和密切随访可能会有帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/146b/7982800/6b2d046802e3/fonc-11-627428-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验